Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virus. Gilmore SA, Tam D, Cheung TL, Snyder C, et al. PLoS One 2022;17:e0271145.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gilmore SA, Tam D, Cheung TL, Snyder C, et al. Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virus. PLoS One 2022;17:e0271145.
PMID: 36477212